Old Web
English
Sign In
Acemap
>
authorDetail
>
John Prescott
John Prescott
Genentech
Melanoma
MAPK/ERK pathway
Pharmacology
MEK inhibitor
Cancer research
2
Papers
62
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Bridging the Gap between Preclinical and Clinical Studies Using Pharmacokinetic–Pharmacodynamic Modeling: An Analysis of GDC-0973, a MEK Inhibitor
2012
Clinical Cancer Research
Harvey Wong
Laurent Vernillet
Amy C. Peterson
Joeseph A Ware
Lillian Lee
Jean-François Martini
Peiwen Yu
Congfen Li
Geoffrey Del Rosario
Edna F. Choo
Klaus P. Hoeflich
Yongchang Shi
Blake T. Aftab
Ron G Aoyama
Sanh Tan Lam
Marcia Belvin
John Prescott
Show All
Source
Cite
Save
Citations (61)
Abstract A250: Preclinical combination efficacy and identification of biomarkers of MEK and PI3K inhibitors in phase I
2009
Molecular Cancer Therapeutics
Klaus P. Hoeflich
Mark Merchant
Doug Den Otter
Jocelyn Chan
Emily Chan
Christine Orr
Lori Friedman
Iris Chan
John Prescott
Leanne Berry
Hartmut Koeppen
Marcia Belvin
Show All
Source
Cite
Save
Citations (1)
1